Human Immunodeficiency Virus (HIV) Drugs Market Growth, Demand, Segment

Posted by vinit sawant on February 9th, 2021

The human immunodeficiency virus (HIV) spreads through body fluids, such as blood and seminal fluid, and attacks the human immune system, especially CD4 cells (often called T cells). The weakening of the immune system results in the occurrence of opportunistic infections and results in acquired immunodeficiency syndrome (AIDS).

Market Forecast

Human Immunodeficiency Virus (HIV) Drugs Market is expected to cross USD 33.7 Million by 2025 at a CAGR of 5% during the forecast period.

Market Influencer

Increasing awareness about HIV treatment, extensive research & development for new drugs, and a large number of patients diagnosed with HIV annually are impacting the market.

Market Drivers

  • Increasing prevalence of HIV infection

The number of individuals diagnosed with HIV has grown exponentially over the years. For instance, in 2018, the number of individuals infected by HIV worldwide was reportedly 1.7 million.

  • Rising awareness about HIV treatment

Due to the rising awareness of HIV infection and its treatment options, the number of individuals undergoing HIV treatment is increasing. For instance, in 2018, 23.3 million HIV patients were undergoing antiretroviral therapy (ART) globally. The number has increased by 1.6 million as compared to 2017 and 8 million as compared to 2010.

Like it? Share it!


vinit sawant

About the Author

vinit sawant
Joined: July 4th, 2019
Articles Posted: 359

More by this author